Pain from a Bullet Lingers on: An Uncommon Case of Lead Toxicity by Abraham, Albin et al.
 
Case Rep Gastroenterol 2012;6:243–248 
DOI: 10.1159/000338843 
Published online: 
May 8, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
This is an Open Access article licensed under the terms of the Creative Commons 
Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable 
to the online version of the article only. Distribution for non-commercial purposes only.   
 
                      Albin Abraham    Department of Internal Medicine, Nassau University Medical Center 
2201 Hempstead Turnpike, East Meadow, NY 11554 (USA) 
Tel. +1 505 688 5451, E-Mail aabraha1 @ numc.edu 
 
243 
   
Pain from a Bullet Lingers on: 
An Uncommon Case of Lead 
Toxicity 
Albin Abraham
a    Jaspreet Singh
b    Paul Mustacchia
b    
Kaleem Rizvon
b 
Departments of 
aInternal Medicine and 
bGastroenterology, Nassau University 
Medical Center, East Meadow, N.Y., USA 
 
 
Key Words 
Lead toxicity · Intra-articular bullets · Abdominal pain · Chelation therapy 
 
 
Abstract 
Lead toxicity from a retained bullet as a cause for abdominal pain is rarely considered. Given 
its unpredictable latent period and nonspecific clinical symptoms, such cases are difficult to 
diagnose but may be fatal if unrecognized. We present the case of a 48-year-old man who 
presented with complaints of abdominal pain, weight loss and constipation. His past history 
was significant for a gunshot wound to the left hip about 20 years before. Radiographic 
studies confirmed the same with the presence of numerous intra-articular bullet fragments 
and a calcified hemarthrosis surrounding the left femoral head. Blood lead levels were 
elevated following which the patient was started on chelation therapy with succimer which 
resulted in symptomatic improvement. The aim of this paper is to highlight the importance 
of considering lead toxicity from a retained bullet as a cause of abdominal pain and to review 
the relevant literature. 
 
Introduction 
Due to its highly desirable properties such as low melting point, malleability, 
durability and low costs, lead has become widely distributed and mobilized in the 
environment. However, lead is also a potent toxin and human exposure to this metal 
has become a health problem of global dimensions. The Adult Blood Lead Epidemiology 
and Surveillance (ABLES) program estimates the prevalence of elevated blood lead 
levels in the Unites States between 2005 and 2007 to be around 7.8 per 100,000 [1]. 
The majority of adult elevated blood lead levels come from work exposure such as 
manufacturing of batteries, pigments, ammunitions and car radiators. Leaded gasoline  
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continues to be used in many parts of the world, which contributes to the atmospheric 
burden. 
Lead poisoning from intra-articular bullets has been recognized since 1867 [2]. The 
diagnosis in most cases is however difficult and often delayed given the vague and 
transient symptoms and the unpredictable time interval to the onset of such symptoms. 
Lead toxicity may manifest as abdominal pain, vomiting, constipation, fatigue, 
arthralgias, headache, decreased libido, hypertension and anorexia. Blood lead levels 
may fluctuate with rapid bone growth, pregnancy, lactation or stressful events such as 
sepsis or surgery. The latent period from exposure to onset of symptoms has been 
reported to range from 2 days to 52 years [3]. Treatment entails chelation therapy and 
definitive surgical removal of the bullet. To reduce the disease burden caused by the 
exposure to lead, it is important to determine the groups at highest risk and the main 
pathways of exposure that contribute to health impacts. 
Case Report 
A 48-year-male presented to our hospital with complaints of abdominal pain and change in bowel 
habits. He described the pain as being constant for the past 3 months, located in his mid abdomen, 
dull and aching in nature, moderate to severe in intensity with no radiation, aggravating or relieving 
factors. He also complained of constipation during the same period associated with a weight loss of 
30 pounds. Review of systems was unremarkable for fever, chills, nausea, vomiting, headache, visual 
complaints, chest pain, shortness of breath, odynophagia, dysphagia, blood per rectum or black stools, 
joint pains, tingling, numbness, paresthesias, muscle weakness or skin rash. The patient had 
emigrated from Guatemala 15 years earlier. He had a recent workup in his native country for the 
abdominal pain which was unremarkable and it was recommended that he be follow up in the United 
States. His past medical history was significant for diabetes mellitus type 2, hypertension and 
hyperlipidemia. The patient also had suffered a gunshot injury to his left hip more than 20 years 
before. Home medications included candesartan, nebivolol, celecoxib, glimepiride and sitagliptin. He 
denied the use of alcohol, tobacco or illicit drugs. He had been employed as a plumber for more than 
10 years in a construction company taking care of old houses. 
On physical examination the patient appeared comfortable and in no apparent distress. Vital signs 
on admission revealed a blood pressure of 170/100 mm Hg, a pulse rate of 68 bpm, a respiratory rate 
of 14 per minute and a temperature 98.3° Fahrenheit. The patient had no conjunctival pallor or scleral 
icterus, oral thrush, gum line or lymphadenopathy. The cardiovascular and respiratory system were 
unremarkable. The abdomen was soft, nondistended with mild periumbilical tenderness but no 
rebound tenderness, rigidity or guarding. There was no organomegaly or any stigmata of chronic liver 
disease. There were no masses or blood on digital rectal examination. There was limitation to the 
range of movement in the left hip joint. 
Laboratory investigations revealed a hemoglobin of 10.4 g/dl and a hematocrit of 30.4% with 
mean corpuscular volume 88.9 fl, mean corpuscular hemoglobin 30.3 pg and red cell distribution 
width 14.4%. Iron studies showed iron to be 111 µg/dl, total iron binding capacity 210 µg/dl, 
transferring saturation 53% and ferritin 613 ng/ml. Liver-related tests, blood chemistry and amylase 
as well as lipase levels were within normal limits. Computed tomography of the abdomen and pelvis 
confirmed the gunshot wound to the left hip with a calcified hemarthrosis surrounding the left 
femoral head (fig. 1, fig. 2). X-ray of the left hip showed advanced degenerative changes to the joint 
with numerous tiny intra-articular bullet fragments (fig. 3). Colonoscopy results revealed spastic 
colon with no other abnormality. The patient’s prior workup was reviewed and showed normal upper 
endoscopy, normal TSH, uric acid and urine porphobilinogen levels. Given the history of the gunshot 
wound confirmed by computed tomography scan and the occupation of the patient, a blood lead level 
was sent which was reported back as being 63.4 μg/dl (elevated blood lead levels are defined as levels 
>25 μg/dl). The peripheral blood smear which was later viewed showed basophilic stippling. The 
Regional Toxicology Center and Department of Health were contacted and the patient was started on 
a 19-day oral succimer chelation therapy. His abdominal pain abated on the fourth day of therapy  
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with improvement also in his bowel movements. He was later discharged with follow-up 
appointments at outpatient clinics and was advised not to join work till his next clinic visit.  
On a follow-up visit in our outpatient clinic 2 weeks after discharge, the patient was symptom-free 
and his blood lead level was 43.5 μg/dl. His hemoglobin had also improved to 12.1 g/dl. He later 
underwent total left hip arthroplasty with removal of the bullet. His blood lead level 1 week after the 
surgery was 39.7 μg/dl. The patient was doing well at the 6-month follow-up evaluation.  
Discussion 
Lead has been mined for thousands of years and was once prized as one of the most 
valuable elements on earth. However in the past century due to tremendous scientific 
data available, the toxic effects of lead on the human body have been demonstrated. 
Tanquerel des Plances described the clinical course of workers, primarily painters, who 
developed lead colic in 1839, leading to the initial interest in the illness caused by lead 
poisoning. Lead poisoning is now considered one of the most common diseases of 
environmental origin. The blood lead levels of Americans as monitored by the National 
Health and Nutrition Examination Survey (NHANES) indicate that the mean blood lead 
levels have declined by more than 80%, from 12.8 µg/dl (in 1976–1980) to a current 
level of 2 µg/dl. Blood lead levels begin to rise in adolescence through adulthood, 
reflecting occupational exposure, and then rise again in the elderly, reflecting 
remobilization of lead as bone resorption occurs. Though the normal lead levels in the 
past were considered to be <40 µg/dl, the presence of subclinical effects of lead at 
lower levels argues for defining lead intoxication as blood lead levels >25 µg/dl [4]. 
The most common sources of lead toxicity are lead paint, air polluted with industrial 
and automobile fumes, contaminated water and soil and occupational exposures as in 
plumbers, miners, welders and battery manufacturers. Among the rarer causes, lead 
poisoning due to retained bullets has often been described in the literature. Bronvin [5] 
recorded the first such case in the modern medical literature in 1867 [6]. Ellis [7] 
published the first English language report of a possible association between retained 
bullets and lead toxicity in 1874. Our patient had two potential etiologies of lead 
toxicity: his occupation and the retained bullet in his left hip. 
Many factors affect the risk of lead toxicity from a retained bullet: location, 
fragmentation, number and lead content of the bullets [8]. Lead bullets in muscle or 
bone generally do not result in toxicity as the tissue surrounding the foreign body 
creates a fibrous capsule and prevents the dissolution of lead into the blood circulation 
[9]. However bullets lodged in joints or in the spinal cord canal are in constant contact 
with the acidic synovial fluid or cerebrospinal fluid. The metallic lead tends to dissolve 
in the acidic media, thereby promoting its absorption, distribution and toxic effects in 
the target tissues and organs. In addition the resultant arthritic inflammation further 
increases vascularity to the joint, accelerating the rate of systemic absorption. Friction 
within a mobile joint can also hasten fragmentation of the bullet [5]. McQuirter et al. 
[10] reported that retained lead bullets are often fragmented (69.2%) and that blood 
lead levels increase by 25.6% with fragmentation mainly by increased surface area of 
absorption. When fragmentation is combined with a torso bone fracture there is a 
further increase in blood lead levels of 29.5%. This can be explained by the fact that the 
torso contains several body cavities which lead fragments are exposed to after a 
penetrating injury. The development of pseudocysts near the bone following a fracture  
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containing finely dispersed lead fragments has also been described [11]. Another 
variable which determines the burden of lead-related toxicity is the lead content in the 
projectile. Bullets and shotgun pellets encountered by US civilians are typically made 
from a lead alloy or are clad bullets with a lead core. Lead bullets which lack a metal 
cover have a greater surface area of lead exposed for dissolution. The variables 
mentioned above can also contribute to the discrepancies in the reported onset of 
symptoms from the initial insult.  
Once in circulation, lead diffuses into the soft tissues including the liver, kidneys, 
bone marrow and brain. After a period of 1–2 months lead diffuses into the bone where 
it is incorporated into the hydroxyapatite lattice. Here it is presumed to be inert and 
nontoxic. However conditions that cause bone mobilization like pregnancy, bed rest, 
medications and advancing age can result in mobilization of lead leading to toxicity. 
Symptoms related to lead toxicity can include peripheral neuropathy, fatigue, 
headaches, memory loss, seizures, hypertension, anemia, gingival lead lines, muscle and 
joint aches. Gastrointestinal manifestations of lead poisoning can include abdominal 
colic, anorexia, weight loss and altered bowel habits. The pathophysiology of these 
symptoms is unclear. Dasani and Kawanishi [12] suggested that lead may induce 
intestinal spasms and interfere with the receptors of the gastrointestinal tract, leading 
to anorexia. Because of lead’s large volume of distribution, the blood lead level is a 
relatively poor indicator of the total lead burden. Nonetheless, since it is easy to obtain 
and provides useful information it is still extremely valuable. X-ray fluorescence is a 
new and promising test that measures the skeletal lead load. Studies show that X-ray 
fluorescence may be more accurate than blood lead level measurement. Other 
laboratory tests that may be useful in evaluation and management include complete 
blood count that may show anemia, peripheral blood smear that may show basophilic 
stippling, renal function tests and δ-aminolevulinic acid dehydratase activity [4]. 
Though definitive management involves surgery to remove the lead fragments, it is 
not usually indicated as the initial therapy for patients with lead toxicity. The patient 
should first be stabilized and the lead burden reduced by chelation therapy. Surgery 
may mobilize bone lead stores by bone or tissue manipulation, stress, physical 
inactivity or metabolic imbalances and thereby result in worsening of lead toxicity even 
leading to death. Parenteral agents used for chelation therapy include dimercaprol and 
calcium disodium ethylene diamine tetraacetic acid (CaNa2EDTA). The two most 
commonly used oral agents are d-penicillamine and succimer. Succimer as was 
administered to our patient is available in 100 mg capsules. The current treatment 
protocol is administration of 10 mg/kg per dose. For the first 5 days it is given every 
8 h, and for the next 14 days every 12 h. Adverse reactions include rash, flu-like 
symptoms and elevated liver transaminases and can be seen in 5% of patients 
[3, 4, 8, 11]. 
McQuirter et al. [10] reported blood lead levels ≥10 µg/dl in 38.1% and levels 
≥20 µg/dl in 11.8% at 3 months post injury. This highlights the need for surveillance in 
patients with retained bullets after gunshot wounds. First, they should have a lead level 
at admission for baseline records. Second, they should have their levels retested before 
discharge or 2 weeks after injury. The patients should be counseled to avoid further 
exposures to lead if occupational exposure is a cause of concern at discharge. Finally 
they should have lead levels checked monthly till 3 months post injury and then 1 year 
post injury. Thereafter they should be advised to obtain yearly blood lead levels.  
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In conclusion, lead toxicity should be excluded in patients presenting with 
nonspecific symptoms such as abdominal pain and with a history of a gunshot wound. 
The health implications are tremendous as there are an estimated 1–2 million gunshot 
wound survivors with retained bullets in the United States, with thousands being added 
yearly. 
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Fig. 1. Computed tomography scan showing a bullet in the left hip with a calcified hemarthrosis 
surrounding the left femoral head.  
 
 
 
Fig. 2. Computed tomography scan showing the bullet in the left hip. 
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Fig. 3. X-ray of the left hip showing advanced posttraumatic arthritic changes including tiny 
intra-articular bullet fragments. 
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